Linked Life Data

2722242

Source:http://linkedlifedata.com/resource/pubmed/id/2722242

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2722242rdf:typepubmed:Citationlld:pubmed
pubmed-article:2722242lifeskim:mentionsumls-concept:C0029341lld:lifeskim
pubmed-article:2722242lifeskim:mentionsumls-concept:C0019168lld:lifeskim
pubmed-article:2722242lifeskim:mentionsumls-concept:C0305062lld:lifeskim
pubmed-article:2722242lifeskim:mentionsumls-concept:C0026809lld:lifeskim
pubmed-article:2722242lifeskim:mentionsumls-concept:C0001060lld:lifeskim
pubmed-article:2722242lifeskim:mentionsumls-concept:C0018909lld:lifeskim
pubmed-article:2722242lifeskim:mentionsumls-concept:C0020852lld:lifeskim
pubmed-article:2722242lifeskim:mentionsumls-concept:C0042210lld:lifeskim
pubmed-article:2722242lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:2722242lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:2722242lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:2722242lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:2722242lifeskim:mentionsumls-concept:C2349975lld:lifeskim
pubmed-article:2722242lifeskim:mentionsumls-concept:C1627358lld:lifeskim
pubmed-article:2722242pubmed:issue6lld:pubmed
pubmed-article:2722242pubmed:dateCreated1989-6-23lld:pubmed
pubmed-article:2722242pubmed:abstractTextThe adjuvant activity of chemically synthesized 6-O-acylated muramyl dipeptides (MDP) was tested in aqueous form. The activity was assessed by determining immunoglobulin G (IgG) titers in sera of mice immunized with hepatitis B virus surface antigen, influenza virus hemagglutinin (HA) vaccine, or tetanus toxoid with an enzyme-linked immunosorbent assay. Administration of 6-O-acyl-MDP analogs with antigens induced marked enhancement of primary and secondary IgG antibody responses and maintained high antibody levels for at least 7 weeks. Among the analogs tested, an MDP methyl ester carrying a 6-O-3-hexadecanoyl-oxytetradecanoyl group (compound 309) exhibited the most intensive adjuvant activity. Its activity was stronger than that of 6-O-2-tetradecylhexadecanoyl (B3O)-MDP used as a positive control. However, accumulation of peritoneal cells and activation of peritoneal macrophages by compound 309 was weaker than that by 6-O-B30-MDP, suggesting that 309 as an immunoadjuvant is more suitable for vaccination in terms of its stronger enhancement of antibody formation and lower induction of inflammatory response than 6-O-B30-MDP.lld:pubmed
pubmed-article:2722242pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2722242pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2722242pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2722242pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2722242pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2722242pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2722242pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2722242pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2722242pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2722242pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2722242pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2722242pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2722242pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2722242pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2722242pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2722242pubmed:languageenglld:pubmed
pubmed-article:2722242pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2722242pubmed:citationSubsetIMlld:pubmed
pubmed-article:2722242pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2722242pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2722242pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2722242pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2722242pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2722242pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2722242pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2722242pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2722242pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2722242pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2722242pubmed:statusMEDLINElld:pubmed
pubmed-article:2722242pubmed:monthJunlld:pubmed
pubmed-article:2722242pubmed:issn0019-9567lld:pubmed
pubmed-article:2722242pubmed:authorpubmed-author:WatanabeMMlld:pubmed
pubmed-article:2722242pubmed:authorpubmed-author:HasegawaAAlld:pubmed
pubmed-article:2722242pubmed:authorpubmed-author:NomotoKKlld:pubmed
pubmed-article:2722242pubmed:authorpubmed-author:KissIIlld:pubmed
pubmed-article:2722242pubmed:authorpubmed-author:NagumoTTlld:pubmed
pubmed-article:2722242pubmed:authorpubmed-author:KumazawaYYlld:pubmed
pubmed-article:2722242pubmed:authorpubmed-author:FuruyaTTlld:pubmed
pubmed-article:2722242pubmed:authorpubmed-author:TakimotoHHlld:pubmed
pubmed-article:2722242pubmed:authorpubmed-author:AizawaCClld:pubmed
pubmed-article:2722242pubmed:issnTypePrintlld:pubmed
pubmed-article:2722242pubmed:volume57lld:pubmed
pubmed-article:2722242pubmed:ownerNLMlld:pubmed
pubmed-article:2722242pubmed:authorsCompleteYlld:pubmed
pubmed-article:2722242pubmed:pagination1839-44lld:pubmed
pubmed-article:2722242pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:2722242pubmed:meshHeadingpubmed-meshheading:2722242-...lld:pubmed
pubmed-article:2722242pubmed:meshHeadingpubmed-meshheading:2722242-...lld:pubmed
pubmed-article:2722242pubmed:meshHeadingpubmed-meshheading:2722242-...lld:pubmed
pubmed-article:2722242pubmed:meshHeadingpubmed-meshheading:2722242-...lld:pubmed
pubmed-article:2722242pubmed:meshHeadingpubmed-meshheading:2722242-...lld:pubmed
pubmed-article:2722242pubmed:meshHeadingpubmed-meshheading:2722242-...lld:pubmed
pubmed-article:2722242pubmed:meshHeadingpubmed-meshheading:2722242-...lld:pubmed
pubmed-article:2722242pubmed:meshHeadingpubmed-meshheading:2722242-...lld:pubmed
pubmed-article:2722242pubmed:meshHeadingpubmed-meshheading:2722242-...lld:pubmed
pubmed-article:2722242pubmed:meshHeadingpubmed-meshheading:2722242-...lld:pubmed
pubmed-article:2722242pubmed:meshHeadingpubmed-meshheading:2722242-...lld:pubmed
pubmed-article:2722242pubmed:meshHeadingpubmed-meshheading:2722242-...lld:pubmed
pubmed-article:2722242pubmed:meshHeadingpubmed-meshheading:2722242-...lld:pubmed
pubmed-article:2722242pubmed:meshHeadingpubmed-meshheading:2722242-...lld:pubmed
pubmed-article:2722242pubmed:meshHeadingpubmed-meshheading:2722242-...lld:pubmed
pubmed-article:2722242pubmed:meshHeadingpubmed-meshheading:2722242-...lld:pubmed
pubmed-article:2722242pubmed:meshHeadingpubmed-meshheading:2722242-...lld:pubmed
pubmed-article:2722242pubmed:year1989lld:pubmed
pubmed-article:2722242pubmed:articleTitleEnhancement of immunoglobulin G responses in mice against hepatitis B virus surface antigen, influenza virus hemagglutinin vaccine, and tetanus toxoid by 6-O-acylated muramyl dipeptides.lld:pubmed
pubmed-article:2722242pubmed:affiliationSchool of Hygienic Sciences, Kitasato University, Sagamihara, Japan.lld:pubmed
pubmed-article:2722242pubmed:publicationTypeJournal Articlelld:pubmed